A detailed history of Truvestments Capital LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Truvestments Capital LLC holds 1,983 shares of NVO stock, worth $173,809. This represents 0.07% of its overall portfolio holdings.

Number of Shares
1,983
Previous 1,954 1.48%
Holding current value
$173,809
Previous $278,000 15.11%
% of portfolio
0.07%
Previous 0.11%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$119.07 - $145.42 $3,453 - $4,217
29 Added 1.48%
1,983 $236,000
Q3 2023

Nov 13, 2023

BUY
$90.94 - $199.54 $91,576 - $200,936
1,007 Added 106.34%
1,954 $177,000
Q2 2023

Aug 10, 2023

BUY
$155.98 - $172.65 $155 - $172
1 Added 0.11%
947 $153,000
Q1 2023

May 12, 2023

BUY
$132.34 - $159.14 $5,955 - $7,161
45 Added 4.99%
946 $150,000
Q3 2022

Nov 14, 2022

BUY
$95.28 - $116.93 $95 - $116
1 Added 0.11%
901 $90,000
Q2 2022

Aug 09, 2022

BUY
$103.24 - $121.81 $92,916 - $109,629
900 New
900 $100,000
Q1 2022

May 02, 2022

SELL
$93.1 - $112.54 $83,696 - $101,173
-899 Closed
0 $0
Q3 2021

Oct 29, 2021

BUY
$84.42 - $106.62 $84 - $106
1 Added 0.11%
899 $86,000
Q2 2021

Aug 12, 2021

BUY
$67.66 - $84.76 $135 - $169
2 Added 0.22%
898 $75,000
Q1 2021

May 18, 2021

SELL
$67.06 - $75.82 $4,291 - $4,852
-64 Reduced 6.67%
896 $60,000
Q4 2020

Feb 17, 2021

BUY
$63.89 - $73.8 $61,334 - $70,848
960 New
960 $67,000
Q3 2020

Nov 13, 2020

SELL
$63.69 - $70.22 $61,078 - $67,340
-959 Closed
0 $0
Q2 2020

Aug 06, 2020

SELL
$58.54 - $67.94 $134,524 - $156,126
-2,298 Reduced 70.56%
959 $62,000
Q1 2020

May 07, 2020

BUY
$49.46 - $64.78 $161,091 - $210,988
3,257 New
3,257 $196,000
Q4 2019

Jan 29, 2020

SELL
$49.86 - $58.26 $131,231 - $153,340
-2,632 Closed
0 $0
Q2 2019

Jul 15, 2019

BUY
$46.79 - $52.47 $111,266 - $124,773
2,378 Added 936.22%
2,632 $134,000
Q3 2018

Oct 22, 2018

BUY
$46.76 - $51.24 $11,877 - $13,014
254 New
254 $12,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $198B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Truvestments Capital LLC Portfolio

Follow Truvestments Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Truvestments Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Truvestments Capital LLC with notifications on news.